This is a preview of subscription content, log in via an institution to check access.
Reference
OCALIVA (obeticholic acid) - New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC) Internet Document : 7 Dec 2022. Available from: URL: https://recalls-rappels.canada.ca/en/alert-recall/ocaliva-obeticholic-acid-new-contraindication-treatment-primary-biliary-cholangitis
Rights and permissions
About this article
Cite this article
OCALIVA now contraindicated in advanced primary biliary cholangitis. Reactions Weekly 1937, 9 (2022). https://doi.org/10.1007/s40278-022-29689-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-29689-1